chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pigmentation disorder, Vaccination complication
Clinical narrative: After the second vaccine she had reactions/feeling some type of way/like she's been used as a guinea pig/looks like a "junkie" walking down the streets; she had black spots and red spots all over her body, on both of her arms, and on her face; constant migraine headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (After the second vaccine she had reactions/feeling some type of way/like she's been used as a guinea pig/looks like a "junkie" walking down the streets), PIGMENTATION DISORDER (she had black spots and red spots all over her body, on both of her arms, and on her face) and MIGRAINE (constant migraine headaches) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 07B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jul-2021, the patient experienced VACCINATION COMPLICATION (After the second vaccine she had reactions/feeling some type of way/like she's been used as a guinea pig/looks like a "junkie" walking down the streets), PIGMENTATION DISORDER (she had black spots and red spots all over her body, on both of her arms, and on her face) and MIGRAINE (constant migraine headaches). At the time of the report, VACCINATION COMPLICATION (After the second vaccine she had reactions/feeling some type of way/like she's been used as a guinea pig/looks like a "junkie" walking down the streets), PIGMENTATION DISORDER (she had black spots and red spots all over her body, on both of her arms, and on her face) and MIGRAINE (constant migraine headaches) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.  Concomitant medications were not provided.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Oropharyngeal pain, Pyrexia, Rash
Clinical narrative: sick after receiving the second dose; fever; rashes on the back; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick after receiving the second dose), PYREXIA (fever), RASH (rashes on the back) and OROPHARYNGEAL PAIN (sore throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick after receiving the second dose), PYREXIA (fever), RASH (rashes on the back) and OROPHARYNGEAL PAIN (sore throat). At the time of the report, ILLNESS (sick after receiving the second dose), PYREXIA (fever), RASH (rashes on the back) and OROPHARYNGEAL PAIN (sore throat) outcome was unknown.            Concomitant medications were not provided.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: second shot>40 days/"My second dose onlt can be get after 40 days later; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (second shot>40 days/"My second dose onlt can be get after 40 days later) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (second shot>40 days/"My second dose onlt can be get after 40 days later). At the time of the report, PRODUCT DOSE OMISSION ISSUE (second shot>40 days/"My second dose onlt can be get after 40 days later) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: Vaccine storage temperature presumed to be between 7.5 C and 9 C; Vaccine has been administered to patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine storage temperature presumed to be between 7.5 C and 9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine has been administered to patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine storage temperature presumed to be between 7.5 C and 9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine has been administered to patients). At the time of the report, PRODUCT STORAGE ERROR (Vaccine storage temperature presumed to be between 7.5 C and 9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine has been administered to patients) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Rash, Sensory disturbance, Vaccination site erythema
Clinical narrative: Sometimes when she lays down she feels a sensation on the nerve; redness; she had a rash around her breast, behund her back; the injection site was red; she had pain the same day; This spontaneous case was reported by a patient and describes the occurrence of PAIN (she had pain the same day), SENSORY DISTURBANCE (Sometimes when she lays down she feels a sensation on the nerve), ERYTHEMA (redness), RASH (she had a rash around her breast, behund her back) and VACCINATION SITE ERYTHEMA (the injection site was red) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety and Blood pressure high. Concomitant products included ESCITALOPRAM for Anxiety, METOPROLOL for Blood pressure high, FISH OIL (OMEGA 3 [FISH OIL]), MAGNESIUM CITRATE, POTASSIUM CITRATE (POTASSIUM MAGNESIUM CITRATE [MAGNESIUM CITRATE;POTASSIUM CITRATE]), VITAMIN C [ASCORBIC ACID], CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM 600 WITH VITAMIN D), MULTIVITAMIN [VITAMINS NOS] and MINERALS for an unknown indication.    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN (she had pain the same day). On 04-Apr-2021, the patient experienced ERYTHEMA (redness). 04-Apr-2021, the patient experienced RASH (she had a rash around her breast, behund her back) and VACCINATION SITE ERYTHEMA (the injection site was red). On an unknown date, the patient experienced SENSORY DISTURBANCE (Sometimes when she lays down she feels a sensation on the nerve). The patient was treated with GABAPENTIN at a dose of 100 mg and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form, q8h(3 to 5 days every 8 hrs). On 07-Apr-2021, ERYTHEMA (redness) had resolved. At the time of the report, PAIN (she had pain the same day), SENSORY DISTURBANCE (Sometimes when she lays down she feels a sensation on the nerve), RASH (she had a rash around her breast, behund her back) and VACCINATION SITE ERYTHEMA (the injection site was red) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-045301 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow up received contains significant information that event redness was recovered
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received his 1st dose of AstraZeneca vaccine in another Country and then received his 1st dose ofModerna vaccine here; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received his 1st dose of AstraZeneca vaccine in another country and then received his 1st dose ofModerna vaccine here) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received his 1st dose of AstraZeneca vaccine in another Country and then received his 1st dose ofModerna vaccine here. In June 2021, INTERCHANGE OF VACCINE PRODUCTS (Patient received his 1st dose of AstraZeneca vaccine in another Country and then received his 1st dose ofModerna vaccine here had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment information was unknown.  The patient per pharmacist got his 1st dose of AstraZeneca vaccine in another Country and then received his 1st dose of Moderna vaccine here in beginning of June,2021 and was inquiring about getting the 2nd dose of Moderna vaccine.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Hyperhidrosis, Sedation
Clinical narrative: Sweating on his pillow/sweat; Dopiness/dopey; Feeling bogged down; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating on his pillow/sweat), SEDATION (Dopiness/dopey), FEELING ABNORMAL (Feeling bogged down) and CHILLS (Chills) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029LZOA and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included HYDROXYCHLOROQUINE for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweating on his pillow/sweat), SEDATION (Dopiness/dopey), FEELING ABNORMAL (Feeling bogged down) and CHILLS (Chills). At the time of the report, HYPERHIDROSIS (Sweating on his pillow/sweat), SEDATION (Dopiness/dopey), FEELING ABNORMAL (Feeling bogged down) and CHILLS (Chills) had resolved.            Concomitant medications included Cellselfazine 500 MG and 2 Drops for Glaucoma. No treatment medication was provided.   This case was linked to MOD-2021-037232 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Broken out in hives  all over the body, It was everywhere, big "welts" and is miserable; Itch; Allergic reaction/allergist due the reaction from the shot; Cannot wear clothes, Cannot go out; Rash is severe, Rash is all over the body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Broken out in hives  all over the body, It was everywhere, big "welts" and is miserable), PRURITUS (Itch), ALLERGY TO VACCINE (Allergic reaction/allergist due the reaction from the shot), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Cannot wear clothes, Cannot go out) and RASH (Rash is severe, Rash is all over the body) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included METHOTREXATE, FOLIC ACID, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and TRIAMCINOLONE for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Broken out in hives  all over the body, It was everywhere, big "welts" and is miserable), PRURITUS (Itch), ALLERGY TO VACCINE (Allergic reaction/allergist due the reaction from the shot), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Cannot wear clothes, Cannot go out) and RASH (Rash is severe, Rash is all over the body). The patient was treated with PREDNISONE for Itch, at an unspecified dose and frequency and HYDROXYZINE for Itch, at an unspecified dose and frequency. At the time of the report, URTICARIA (Broken out in hives  all over the body, It was everywhere, big "welts" and is miserable), PRURITUS (Itch), ALLERGY TO VACCINE (Allergic reaction/allergist due the reaction from the shot), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Cannot wear clothes, Cannot go out) and RASH (Rash is severe, Rash is all over the body) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: increased (High) Prednisone shot her blood sugar up.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    The patient had a schedule appointment with her allergist due the reaction from the shot. She stated that rash was severe and was an allergic reaction. The rash was all over the body such as scalp, armpits, ears and everywhere on the body except for her feet.The patient reported that it was everywhere and went to dermatologist who started patient on prednisone and cream for her itch; She stated that her symptoms went away and came right back. She stated that she is diabetic, so prednisone shot her blood sugar up. Lab data included  biopsy and blood test with no result.   This case was linked to MOD-2021-254144 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: had an adverse event; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had an adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (had an adverse event). At the time of the report, VACCINATION COMPLICATION (had an adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Swelling
Clinical narrative: swollen area that starts from armpit and goes to mid-trunk; swollen area that starts from armpit and goes to mid-trunk. The swelling is very painful.; swollen armpit; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swollen area that starts from armpit and goes to mid-trunk), PAIN (swollen area that starts from armpit and goes to mid-trunk. The swelling is very painful.) and LYMPHADENOPATHY (swollen armpit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (swollen area that starts from armpit and goes to mid-trunk), PAIN (swollen area that starts from armpit and goes to mid-trunk. The swelling is very painful.) and LYMPHADENOPATHY (swollen armpit). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, SWELLING (swollen area that starts from armpit and goes to mid-trunk), PAIN (swollen area that starts from armpit and goes to mid-trunk. The swelling is very painful.) and LYMPHADENOPATHY (swollen armpit) outcome was unknown.            Concomitant medication was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Discomfort, Fatigue, Headache
Clinical narrative: pain radiating up her right arm (same arm as injection) to the shoulder and neck,; Nausea; General fatigue; Headache; Pain all over different parts of her body; Back pain, couldn't get out of bed; Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain; Neck and shoulder pain returned; Discomfort in right hand, knuckle tender to the touch; discomfort in her right hand where her knuckle was tender to the touch; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache) and MYALGIA (Pain all over different parts of her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache), MYALGIA (Pain all over different parts of her body), BACK PAIN (Back pain, couldn't get out of bed), ARTHRALGIA (Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain), NECK PAIN (Neck and shoulder pain returned), TENDERNESS (Discomfort in right hand, knuckle tender to the touch) and DISCOMFORT (discomfort in her right hand where her knuckle was tender to the touch). At the time of the report, PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache), MYALGIA (Pain all over different parts of her body), BACK PAIN (Back pain, couldn't get out of bed), ARTHRALGIA (Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain), NECK PAIN (Neck and shoulder pain returned), TENDERNESS (Discomfort in right hand, knuckle tender to the touch) and DISCOMFORT (discomfort in her right hand where her knuckle was tender to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Neck pain, Pain in extremity, Tenderness
Clinical narrative: pain radiating up her right arm (same arm as injection) to the shoulder and neck,; Nausea; General fatigue; Headache; Pain all over different parts of her body; Back pain, couldn't get out of bed; Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain; Neck and shoulder pain returned; Discomfort in right hand, knuckle tender to the touch; discomfort in her right hand where her knuckle was tender to the touch; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache) and MYALGIA (Pain all over different parts of her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache), MYALGIA (Pain all over different parts of her body), BACK PAIN (Back pain, couldn't get out of bed), ARTHRALGIA (Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain), NECK PAIN (Neck and shoulder pain returned), TENDERNESS (Discomfort in right hand, knuckle tender to the touch) and DISCOMFORT (discomfort in her right hand where her knuckle was tender to the touch). At the time of the report, PAIN IN EXTREMITY (pain radiating up her right arm (same arm as injection) to the shoulder and neck,), NAUSEA (Nausea), FATIGUE (General fatigue), HEADACHE (Headache), MYALGIA (Pain all over different parts of her body), BACK PAIN (Back pain, couldn't get out of bed), ARTHRALGIA (Left hip pain, that persisted and she could barely walk\ pain in ankle\pain in left elbow\shoulder pain), NECK PAIN (Neck and shoulder pain returned), TENDERNESS (Discomfort in right hand, knuckle tender to the touch) and DISCOMFORT (discomfort in her right hand where her knuckle was tender to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Malaise
Clinical narrative: Stuffy Nose (After Second Shot); Cough (After Second Shot); Malaise (After Second Shot); Lack of Taste  (After Second Shot); Lack of Smell   (After Second Shot); Mild COVID-19 Disease (After Second Shot); This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)) and ANOSMIA (Lack of Smell   (After Second Shot)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jun-2021, the patient experienced NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)), ANOSMIA (Lack of Smell   (After Second Shot)) and COVID-19 (Mild COVID-19 Disease (After Second Shot)). On 12-Jul-2021, NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)), ANOSMIA (Lack of Smell   (After Second Shot)) and COVID-19 (Mild COVID-19 Disease (After Second Shot)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jun-2021, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, SARS-CoV-2 test
Clinical narrative: Stuffy Nose (After Second Shot); Cough (After Second Shot); Malaise (After Second Shot); Lack of Taste  (After Second Shot); Lack of Smell   (After Second Shot); Mild COVID-19 Disease (After Second Shot); This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)) and ANOSMIA (Lack of Smell   (After Second Shot)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jun-2021, the patient experienced NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)), ANOSMIA (Lack of Smell   (After Second Shot)) and COVID-19 (Mild COVID-19 Disease (After Second Shot)). On 12-Jul-2021, NASAL CONGESTION (Stuffy Nose (After Second Shot)), COUGH (Cough (After Second Shot)), MALAISE (Malaise (After Second Shot)), AGEUSIA (Lack of Taste  (After Second Shot)), ANOSMIA (Lack of Smell   (After Second Shot)) and COVID-19 (Mild COVID-19 Disease (After Second Shot)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jun-2021, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: top of her shoulder hurt a little bit after first dose; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (top of her shoulder hurt a little bit after first dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included METOPROLOL and LOSARTAN for Blood pressure management.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (top of her shoulder hurt a little bit after first dose). At the time of the report, ARTHRALGIA (top of her shoulder hurt a little bit after first dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Treatment information for dose 1 events was provided.   This case was linked to MOD-2021-254186 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Administration site inflammation, Pyrexia, Rash, Vaccination site pruritus
Clinical narrative: red inflammation; rash; itchiness at site of injection; fever at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of ADMINISTRATION SITE INFLAMMATION (red inflammation), RASH (rash), VACCINATION SITE PRURITUS (itchiness at site of injection) and PYREXIA (fever at site of injection) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001R21A and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Glaucoma since an unknown date. Concurrent medical conditions included Blood pressure high. Concomitant products included HYDROCHLOROTHIAZID for Blood pressure high, ATORVASTATIN for Cholesterol, DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (COSOPT) and BIMATOPROST (LUMIGAN) for Glaucoma.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced ADMINISTRATION SITE INFLAMMATION (red inflammation), RASH (rash), VACCINATION SITE PRURITUS (itchiness at site of injection) and PYREXIA (fever at site of injection). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. At the time of the report, ADMINISTRATION SITE INFLAMMATION (red inflammation), RASH (rash), VACCINATION SITE PRURITUS (itchiness at site of injection) and PYREXIA (fever at site of injection) had resolved.            Patient used Ice for treatment.   This case was linked to MOD-2021-015718 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Vaccination site rash
Clinical narrative: felt tired; Muscle aches; noticed a slight rash like area at the injection site; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (felt tired), MYALGIA (Muscle aches) and VACCINATION SITE RASH (noticed a slight rash like area at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes (A1C has lowered from 6.2 to 5.8 due to change in diet and exercise.) since 2005, Cholesterol (lower cholesterol numbers due to diet and exercise.) since 2005 and Hypertension (BP lower due to diet and exercise.) since 2005. Concomitant products included GLIPIZIDE and METFORMIN for Diabetes, CARVEDILOL for High cholesterol, ATORVASTATIN for Hypertension.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (felt tired), MYALGIA (Muscle aches) and VACCINATION SITE RASH (noticed a slight rash like area at the injection site). At the time of the report, FATIGUE (felt tired), MYALGIA (Muscle aches) and VACCINATION SITE RASH (noticed a slight rash like area at the injection site) had resolved. Not provided.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Treatment medication was provided.   This case was linked to MOD-2021-027508 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Productive cough
Clinical narrative: Cough/phlem /Phlem feels like it doesn't want to come up and it almost chokes; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (Cough/phlem /Phlem feels like it doesn't want to come up and it almost chokes) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027a21a and 30300161221a) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included BRINZOLAMIDE (AZOPT) from 01-Feb-2010 to an unknown date and TAFLUPROST (ZIOPTAN) from 25-Jan-2009 to an unknown date for Glaucoma, DILTIAZEM from 03-Jan-1986 to an unknown date for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) from 06-Jan-1984 to an unknown date for Hypothyroidism, VEDOLIZUMAB (ENTYVIO) from 04-Jan-2014 to an unknown date for Ulcerative colitis.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCTIVE COUGH (Cough/phlem /Phlem feels like it doesn't want to come up and it almost chokes). At the time of the report, PRODUCTIVE COUGH (Cough/phlem /Phlem feels like it doesn't want to come up and it almost chokes) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Chest X-ray: negative (Negative) Negative.         Treatment Information was not provided by Reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow-up was received and contains no new information.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Decreased appetite, Discomfort, Fatigue, Head discomfort
Clinical narrative: Discomfort in neck and head; Pain goes up to her neck and beyond her ear / neck hurts; can't sleep; can't eat; she's stiff and very uncomfortable; pain in the left arm / first it was just achy; very uncomfortable; discomfort head; Is tired of hurting; joints hurt too; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Discomfort in neck and head), NECK PAIN (Pain goes up to her neck and beyond her ear / neck hurts), INSOMNIA (can't sleep), DECREASED APPETITE (can't eat) and MUSCULOSKELETAL STIFFNESS (she's stiff and very uncomfortable) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL and LOSARTAN for Blood pressure high.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Discomfort in neck and head), NECK PAIN (Pain goes up to her neck and beyond her ear / neck hurts), INSOMNIA (can't sleep), DECREASED APPETITE (can't eat), MUSCULOSKELETAL STIFFNESS (she's stiff and very uncomfortable), PAIN IN EXTREMITY (pain in the left arm / first it was just achy), DISCOMFORT (very uncomfortable), HEAD DISCOMFORT (discomfort head), FATIGUE (Is tired of hurting) and ARTHRALGIA (joints hurt too). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Discomfort in neck and head), NECK PAIN (Pain goes up to her neck and beyond her ear / neck hurts), INSOMNIA (can't sleep), DECREASED APPETITE (can't eat), MUSCULOSKELETAL STIFFNESS (she's stiff and very uncomfortable), PAIN IN EXTREMITY (pain in the left arm / first it was just achy), DISCOMFORT (very uncomfortable), HEAD DISCOMFORT (discomfort head), FATIGUE (Is tired of hurting) and ARTHRALGIA (joints hurt too) outcome was unknown.            Treatment included hot compresses and baths   This case was linked to MOD-2021-254177 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Musculoskeletal discomfort, Musculoskeletal stiffness, Neck pain, Pain in extremity
Clinical narrative: Discomfort in neck and head; Pain goes up to her neck and beyond her ear / neck hurts; can't sleep; can't eat; she's stiff and very uncomfortable; pain in the left arm / first it was just achy; very uncomfortable; discomfort head; Is tired of hurting; joints hurt too; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Discomfort in neck and head), NECK PAIN (Pain goes up to her neck and beyond her ear / neck hurts), INSOMNIA (can't sleep), DECREASED APPETITE (can't eat) and MUSCULOSKELETAL STIFFNESS (she's stiff and very uncomfortable) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL and LOSARTAN for Blood pressure high.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Discomfort in neck and head), NECK PAIN (Pain goes up to her neck and beyond her ear / neck hurts), INSOMNIA (can't sleep), DECREASED APPETITE (can't eat), MUSCULOSKELETAL STIFFNESS (she's stiff and very uncomfortable), PAIN IN EXTREMITY (pain in the left arm / first it was just achy), DISCOMFORT (very uncomfortable), HEAD DISCOMFORT (discomfort head), FATIGUE (Is tired of hurting) and ARTHRALGIA (joints hurt too). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Discomfort in neck and head), NECK PAIN (Pain goes up to her neck and beyond her ear / neck hurts), INSOMNIA (can't sleep), DECREASED APPETITE (can't eat), MUSCULOSKELETAL STIFFNESS (she's stiff and very uncomfortable), PAIN IN EXTREMITY (pain in the left arm / first it was just achy), DISCOMFORT (very uncomfortable), HEAD DISCOMFORT (discomfort head), FATIGUE (Is tired of hurting) and ARTHRALGIA (joints hurt too) outcome was unknown.            Treatment included hot compresses and baths   This case was linked to MOD-2021-254177 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Feeding disorder, Impaired healing, Inflammation
Clinical narrative: cannot eat or drink water since her throat is irritated; cannot eat or drink water since her throat is irritated; feels that her foot  fracture that  not healing as well; progressively getting worse; sore arm, painful foot; coughing which is getting horrible; painful throat; whole body inflammation from inside out but not  visible; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm, painful foot), COUGH (coughing which is getting horrible), OROPHARYNGEAL PAIN (painful throat), INFLAMMATION (whole body inflammation from inside out but not  visible) and THROAT IRRITATION (cannot eat or drink water since her throat is irritated) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Foot fracture and Allergy to animal (Singular for cat allergy). Concomitant products included GABAPENTIN and VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (sore arm, painful foot), COUGH (coughing which is getting horrible), OROPHARYNGEAL PAIN (painful throat), INFLAMMATION (whole body inflammation from inside out but not  visible) and CONDITION AGGRAVATED (progressively getting worse). On an unknown date, the patient experienced THROAT IRRITATION (cannot eat or drink water since her throat is irritated), FEEDING DISORDER (cannot eat or drink water since her throat is irritated) and IMPAIRED HEALING (feels that her foot  fracture that  not healing as well). The patient was treated with MONTELUKAST SODIUM (SINGULAIR) ongoing since an unknown date for Allergy to animal, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm, painful foot), COUGH (coughing which is getting horrible), OROPHARYNGEAL PAIN (painful throat), INFLAMMATION (whole body inflammation from inside out but not  visible) and CONDITION AGGRAVATED (progressively getting worse) had not resolved and THROAT IRRITATION (cannot eat or drink water since her throat is irritated), FEEDING DISORDER (cannot eat or drink water since her throat is irritated) and IMPAIRED HEALING (feels that her foot  fracture that  not healing as well) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) Negative.         No treatment medication was reported.   This case was linked to MOD-2021-004244 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain in extremity, SARS-CoV-2 test, Throat irritation
Clinical narrative: cannot eat or drink water since her throat is irritated; cannot eat or drink water since her throat is irritated; feels that her foot  fracture that  not healing as well; progressively getting worse; sore arm, painful foot; coughing which is getting horrible; painful throat; whole body inflammation from inside out but not  visible; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm, painful foot), COUGH (coughing which is getting horrible), OROPHARYNGEAL PAIN (painful throat), INFLAMMATION (whole body inflammation from inside out but not  visible) and THROAT IRRITATION (cannot eat or drink water since her throat is irritated) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Foot fracture and Allergy to animal (Singular for cat allergy). Concomitant products included GABAPENTIN and VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (sore arm, painful foot), COUGH (coughing which is getting horrible), OROPHARYNGEAL PAIN (painful throat), INFLAMMATION (whole body inflammation from inside out but not  visible) and CONDITION AGGRAVATED (progressively getting worse). On an unknown date, the patient experienced THROAT IRRITATION (cannot eat or drink water since her throat is irritated), FEEDING DISORDER (cannot eat or drink water since her throat is irritated) and IMPAIRED HEALING (feels that her foot  fracture that  not healing as well). The patient was treated with MONTELUKAST SODIUM (SINGULAIR) ongoing since an unknown date for Allergy to animal, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm, painful foot), COUGH (coughing which is getting horrible), OROPHARYNGEAL PAIN (painful throat), INFLAMMATION (whole body inflammation from inside out but not  visible) and CONDITION AGGRAVATED (progressively getting worse) had not resolved and THROAT IRRITATION (cannot eat or drink water since her throat is irritated), FEEDING DISORDER (cannot eat or drink water since her throat is irritated) and IMPAIRED HEALING (feels that her foot  fracture that  not healing as well) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) Negative.         No treatment medication was reported.   This case was linked to MOD-2021-004244 (Patient Link).
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Mental disorder, Product dose omission issue
Clinical narrative: brother in law who has been mentally ill for years/He later became mentally unstable; Passed the 35 days for receiving the second dose; This spontaneous case was reported by an other caregiver and describes the occurrence of MENTAL DISORDER (brother in law who has been mentally ill for years/He later became mentally unstable) and PRODUCT DOSE OMISSION ISSUE (Passed the 35 days for receiving the second dose) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Mental retardation.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MENTAL DISORDER (brother in law who has been mentally ill for years/He later became mentally unstable) and PRODUCT DOSE OMISSION ISSUE (Passed the 35 days for receiving the second dose). At the time of the report, MENTAL DISORDER (brother in law who has been mentally ill for years/He later became mentally unstable) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Passed the 35 days for receiving the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug was not reported.  Treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Illness, Lichen planopilaris, Weight decreased
Clinical narrative: sick ever since; went from 100 lbs to 85 lbs; has brain fog; planopilaris on her scalp which started small,it has gotten progressively worse and not getting better,this one massive; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick ever since), LICHEN PLANOPILARIS (planopilaris on her scalp which started small,it has gotten progressively worse and not getting better,this one massive), WEIGHT DECREASED (went from 100 lbs to 85 lbs) and FEELING ABNORMAL (has brain fog) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 046B21A) for COVID-19 vaccination.     Concomitant products included TRIAMCINOLONE ACETONIDE (KENALOG [TRIAMCINOLONE ACETONIDE]) for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced LICHEN PLANOPILARIS (planopilaris on her scalp which started small,it has gotten progressively worse and not getting better,this one massive). On an unknown date, the patient experienced ILLNESS (sick ever since), WEIGHT DECREASED (went from 100 lbs to 85 lbs) and FEELING ABNORMAL (has brain fog). The patient was treated with PREDNISONE at a dose of 30 milligram once a day; PREDNISONE at a dose of 20 milligram; PREDNISONE at a dose of 10 milligram and DOXYCYCLINE at a dose of 1 dosage form. At the time of the report, ILLNESS (sick ever since), LICHEN PLANOPILARIS (planopilaris on her scalp which started small,it has gotten progressively worse and not getting better,this one massive), WEIGHT DECREASED (went from 100 lbs to 85 lbs) and FEELING ABNORMAL (has brain fog) was resolving.            The concomitant medication includes- Anti-anxiety medication for unknown  indication.  The patient was on third round of doxycycline and prednisone. The skin and scalp were to clear up, the brain felt sharp again. The patient was working on gaining back the 15 lbs of weight lost.     Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: event outcome updated